Table 1.
Count/Median | Percentage/ IQR (25 th -75 th percentile) | Count N | |
---|---|---|---|
Age (years) | 59.9 | 49.2 – 65.7 | 66 |
Female | 34 | 52% | 66 |
Age of asthma diagnosis (years) | 18.5 | 6.0 – 42.0 | 66 |
Currently Employed | 43 | 65% | 66 |
Ex-smoker | 19 | 29% | 66 |
Ex-smoker Pack years | 1.7 | 0.50 – 5.00 | 19 |
Atopic asthma | 50 | 76% | 66 |
Past 12 months unscheduled doctors visit | 38 | 58% | 66 |
Past 12 months oral corticosteroids | 28 | 42% | 66 |
Past 12 months hospitalisation | 5 | 8% | 66 |
Asthma control score (ACQ) | 1.41 | 1.00 – 2.14 | 66 |
Quality of Life Total Score | 5.71 | 4.81 – 6.44 | 66 |
FEV1% predicted | 69.4 | 53.0 – 82.4 | 66 |
FEV1/FVC | 66.7 | 58.0 – 76.0 | 66 |
ICS dose/1000 (mg/day)† | 2 | 1 – 2 | 65 |
PD15 ‡ | 4.84 | 1.39 – 14.26 | 42 |
Dose response slope* | 2.59 | 0.76 – 5.59 | 53 |
Count and percentage displayed for categorical variables and median and IQR otherwise.
†Inhaled corticosteroids normalisation: 1 μg beclomethasone = 1 μg budesonide = 0.5 μg fluticasone.
‡PD15: provocation dose causing fall in FEV1 of ≥15% from baseline.
*Dose response slope: % fall FEV1/mL 4.5% saline.